SII, the world's biggest vaccine manufacturer, has now provided all the data, the two sources said. Both sources said Indian health officials were in direct contact with their British counterparts over the AstraZeneca shot and that there were “strong indications” an approval would come by next week. The Indian regulator is only considering the two full-dose regimen of the shot despite it showing a lower success rate, the sources said. “Initially, we may get around 50 million to 60 million doses.”The sources declined to be named as deliberations were ongoing and the timeline could change. India has not yet signed a vaccine supply deal with any company, but SII has already stockpiled more than 50 million doses of the AstraZeneca shot and plans to make a total of 400 million doses by July.

Source: bd News24 December 22, 2020 17:48 UTC